跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Revlimid Capsules 10mg - HSA Drug Approval Details
Approvals
/
HSA
/
Revlimid Capsules 10mg
Approved
STANDARD
Revlimid Capsules 10mg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
5b8fa8663a2139ef
Company
Unknown
Type
Standard
Approval Details
Approval Id
5b8fa8663a2139ef
Drug Name
Revlimid Capsules 10mg
Active Ingredients
Lenalidomide
10.0 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
5b8fa8663a2139ef
Type
Standard
Back to HSA Approvals